Literature DB >> 24094286

Differences in the prognostic implications of vascular invasion between lung adenocarcinoma and squamous cell carcinoma.

Shingo Usui1, Yuko Minami, Toshihiro Shiozawa, Shinji Iyama, Kaishi Satomi, Shingo Sakashita, Yukio Sato, Masayuki Noguchi.   

Abstract

OBJECTIVES: Vascular invasion (VI) has been accepted as a universally important prognostic factor for patients with lung carcinoma. However, the clinical significance of VI in each of the histological subtypes has been unclear. The aim of the present study was to investigate differences in the clinicopathological implications of VI between adenocarcinoma and squamous cell carcinoma.
METHOD: A total of 336 patients were evaluated, of whom 81 were diagnosed as having peripheral-type squamous cell carcinoma, and 255 as having adenocarcinoma. RESULT: Among the 336 patients, the five-year survival rates for those who were VI-positive and VI-negative were 38.4% and 76.3%, respectively, the difference being significant (p<0.0001). Multivariate analysis identified VI as an independent prognostic factor (hazard ratio: 1.86). Although the difference in cancer-free survival between VI-positive and -negative patients was statistically significant for adenocarcinoma (p<0.0001), it was not significant for squamous cell carcinoma (p=0.086). For adenocarcinoma, the difference between the survival curves for VI-positive and -negative patients was significant for the subtypes with a predominant lepidic (p<0.0001), papillary (p=0.0026), and acinar (p=0.0060) component, whereas that for the predominantly solid subtype was not significant (p=0.58). Squamous cell carcinomas were then divided into two groups on the basis of the diameter of vessels that had been invaded by the cancer cells: large-vessel invasion (LVI; 1000 μm or more) and small-vessel invasion (SVI; less than 1000 μm). Although there was no difference in the survival curves between the LVI and SVI groups, the LVI group showed a significantly higher incidence of cavity formation and distant metastasis.
CONCLUSION: We conclude that VI is a useful prognostic indicator in lung carcinoma, although the clinical implications of VI differ between adenocarcinoma and squamous cell carcinoma.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Adenocarcinoma; Cavity formation; Large-vessel invasion; Peripheral-type squamous cell carcinoma; Prognosis; Vascular invasion

Mesh:

Substances:

Year:  2013        PMID: 24094286     DOI: 10.1016/j.lungcan.2013.09.001

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  11 in total

1.  Radiomic signature as a diagnostic factor for histologic subtype classification of non-small cell lung cancer.

Authors:  Xinzhong Zhu; Di Dong; Zhendong Chen; Mengjie Fang; Liwen Zhang; Jiangdian Song; Dongdong Yu; Yali Zang; Zhenyu Liu; Jingyun Shi; Jie Tian
Journal:  Eur Radiol       Date:  2018-02-15       Impact factor: 5.315

2.  Unique intravascular tumor microenvironment predicting recurrence of lung squamous cell carcinoma.

Authors:  Kakeru Hisakane; Koichi Saruwatari; Satoshi Fujii; Keisuke Kirita; Shigeki Umemura; Shingo Matsumoto; Kiyotaka Yoh; Seiji Niho; Hironobu Ohmatsu; Takeshi Kuwata; Atsushi Ochiai; Akihiko Gemma; Masahiro Tsuboi; Koichi Goto; Genichiro Ishii
Journal:  J Cancer Res Clin Oncol       Date:  2015-10-31       Impact factor: 4.553

3.  Difference in Postsurgical Prognostic Factors between Lung Adenocarcinoma and Squamous Cell Carcinoma.

Authors:  Haruhiko Nakamura; Hiroki Sakai; Hiroyuki Kimura; Tomoyuki Miyazawa; Hideki Marushima; Hisashi Saji
Journal:  Ann Thorac Cardiovasc Surg       Date:  2017-10-02       Impact factor: 1.520

4.  Target of obstructive sleep apnea syndrome merge lung cancer: based on big data platform.

Authors:  Lifeng Li; Jingli Lu; Wenhua Xue; Liping Wang; Yunkai Zhai; Zhirui Fan; Ge Wu; Feifei Fan; Jieyao Li; Chaoqi Zhang; Yi Zhang; Jie Zhao
Journal:  Oncotarget       Date:  2017-03-28

5.  Identification of microRNA differentially expressed in three subtypes of non-small cell lung cancer and in silico functional analysis.

Authors:  Yanjun Hu; Luqing Wang; Jingxian Gu; Kai Qu; Yunxia Wang
Journal:  Oncotarget       Date:  2017-08-12

6.  Cavity Formation is a Prognostic Indicator for Pathologic Stage I Invasive Lung Adenocarcinoma of ≥3 cm in Size.

Authors:  Chunji Chen; Shijie Fu; Qiming Ni; Wang Yiyang; Xufeng Pan; Jiao Jing; Heng Zhao; Wang Rui
Journal:  Med Sci Monit       Date:  2019-11-27

7.  Urinary N1, N12-diacetylspermine is a non-invasive marker for the diagnosis and prognosis of non-small-cell lung cancer.

Authors:  Yusuke Takahashi; Koji Sakaguchi; Hirotoshi Horio; Kyoko Hiramatsu; Shunsuke Moriya; Keiichi Takahashi; Masao Kawakita
Journal:  Br J Cancer       Date:  2015-10-27       Impact factor: 7.640

8.  Genomic instability in mutant p53 cancer cells upon entotic engulfment.

Authors:  Hannah L Mackay; David Moore; Callum Hall; Nicolai J Birkbak; Mariam Jamal-Hanjani; Saadia A Karim; Vinaya M Phatak; Lucia Piñon; Jennifer P Morton; Charles Swanton; John Le Quesne; Patricia A J Muller
Journal:  Nat Commun       Date:  2018-08-03       Impact factor: 14.919

9.  Prognostic significance of peripheral CD8+CD28+ and CD8+CD28- T cells in advanced non-small cell lung cancer patients treated with chemo(radio)therapy.

Authors:  Chao Liu; Wang Jing; Ning An; Aijie Li; Weiwei Yan; Hui Zhu; Jinming Yu
Journal:  J Transl Med       Date:  2019-10-17       Impact factor: 5.531

10.  Lung cancer associated with cystic airspaces: CT and pathological features.

Authors:  Xinfu Pan; Huan Wang; Hang Yu; Zhijun Chen; Zhaoye Wang; Lie Wang; Jun Chen
Journal:  Transl Cancer Res       Date:  2020-06       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.